Merck (NYSE: MRK) announced that Japan's Ministry of Health, Labor and Welfare has approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA